Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22431716 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna
Conditions: Cancer;   Lentigo Maligna
Interventions: Drug: Imiquimod Cream;   Drug: Tazarotene Cream 0.1%

Indicates status has not been verified in more than two years